Saint Alphonsus Brings Latest in Non-Invasive Robotic Procedure for Prostate Cancer

An estimated 1 in 8 men will be diagnosed with prostate cancer in their life, according to the American Cancer Society, and in Idaho, the rate of prostate cancer is higher than national averages, making access to technological solutions critical in earlier detection and diagnosis.

Saint Alphonsus is addressing this need with groundbreaking, non-invasive robotic technology for the treatment of prostate cancer patients known as the Focal One Robotic High-Intensity Focused Ultrasound (HIFU) technology. This is the only technology of its kind in the state of Idaho and within 400 miles of Boise.  

“The procedure is non-invasive, meaning no blade, scar, radiation, or incision is involved,” said Shelly Gorman, Saint Alphonsus Health System’s Oncology and General Surgery Service Line Director. “HIFU is part of Saint Alphonsus’s ongoing commitment to offer cutting-edge and advanced minimally invasive and robotic surgical procedures to our patients. It supports in our mission to provide care close-to-home so patients will no longer need to leave the community to receive this care.”  

HIFU applies high-intensity ultrasound waves to remove prostate tissue. By focusing these waves on the affected area in one session under general anesthesia, HIFU causes localized heating that destroys the cells within the gland without harming healthy tissue nearby. The risk of side effects, such as incontinence and erectile dysfunction, following the treatment is low compared to conventional radiation therapy. The HIFU procedure also improves quality of life, by reducing treatment from months to days.

The first HIFU procedure is slated for February 26 at Saint Alphonsus Regional Medical Center in Boise.

For patients and caregivers interested in more information on this treatment option, visit https://www.saintalphonsus.org/services/cancer-care/high-frequency-ultrasound.